HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apoptotic mechanisms in neurodegeneration: possible relevance to glaucoma.

Abstract
Deprenyl, a monoamine oxidase inhibitor used in the treatment of Parkinson's disease, along with its primary metabolite desmethyldeprenyl (DES) have been shown to reduce neuronal apoptosis by a mechanism that requires gene transcription and involves the maintenance of mitochondrial membrane potential. This review article explores the mechanisms by which DES maintains mitochondrial membrane potential. Mediated by GAPDH binding, DES increases mitochondrial BCL-2 and BCL-xL levels and decreases BAX levels thereby preventing the permeability transition pore (PTP) form opening and preventing apoptotic degradation. The favorable effects of deprenyl on neuronal apoptosis suggests the therapeutic potential of designing compounds with the capacity to alter the configurations of pro-apoptosis or anti-apoptotic proteins.
AuthorsW G Tatton
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 1999 Jan-Mar Vol. 9 Suppl 1 Pg. S22-9 ISSN: 1120-6721 [Print] United States
PMID10230602 (Publication Type: Journal Article, Review)
Chemical References
  • BAX protein, human
  • BCL2L1 protein, human
  • Monoamine Oxidase Inhibitors
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • Selegiline
  • Glyceraldehyde-3-Phosphate Dehydrogenases
Topics
  • Animals
  • Apoptosis
  • Glaucoma (metabolism, physiopathology)
  • Glyceraldehyde-3-Phosphate Dehydrogenases (metabolism)
  • Humans
  • Membrane Potentials
  • Mitochondria (drug effects, metabolism)
  • Monoamine Oxidase Inhibitors (pharmacology)
  • Nerve Degeneration (physiopathology)
  • Optic Nerve (drug effects, metabolism, physiopathology)
  • Proto-Oncogene Proteins (metabolism)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Selegiline (pharmacology)
  • bcl-2-Associated X Protein
  • bcl-X Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: